Published in J Am Vet Med Assoc on November 15, 1991
A putative cell surface receptor for anemia-inducing feline leukemia virus subgroup C is a member of a transporter superfamily. J Virol (1999) 1.48
Function of a unique sequence motif in the long terminal repeat of feline leukemia virus isolated from an unusual set of naturally occurring tumors. J Virol (1995) 1.13
Feline leukemia virus and other pathogens as important threats to the survival of the critically endangered Iberian lynx (Lynx pardinus). PLoS One (2009) 1.12
Comparative genome organization of human, murine, and feline MHC class II region. Genome Res (2003) 1.09
Subtle mutational changes in the SU protein of a natural feline leukemia virus subgroup A isolate alter disease spectrum. J Virol (2005) 1.04
Feline leukemia virus immunity induced by whole inactivated virus vaccination. Vet Immunol Immunopathol (2009) 0.99
Unique long terminal repeat and surface glycoprotein gene sequences of feline leukemia virus as determinants of disease outcome. J Virol (2005) 0.98
The use of retroviral vectors for gene therapy-what are the risks? A review of retroviral pathogenesis and its relevance to retroviral vector-mediated gene delivery. Genet Vaccines Ther (2004) 0.97
A trap, neuter, and release program for feral cats on Prince Edward Island. Can Vet J (2002) 0.97
Detection of feline leukemia virus RNA in saliva from naturally infected cats and correlation of PCR results with those of current diagnostic methods. J Clin Microbiol (2006) 0.96
Evaluation of feline immunodeficiency virus and feline leukemia virus transmembrane peptides for serological diagnosis. J Clin Microbiol (1992) 0.94
Clinical aspects of feline retroviruses: a review. Viruses (2012) 0.91
Identification of a feline leukemia virus variant that can use THTR1, FLVCR1, and FLVCR2 for infection. J Virol (2009) 0.91
A targeted mutation within the feline leukemia virus (FeLV) envelope protein immunosuppressive domain to improve a canarypox virus-vectored FeLV vaccine. J Virol (2013) 0.90
The feline leukemia virus long terminal repeat contains a potent genetic determinant of T-cell lymphomagenicity. J Virol (1997) 0.90
Viral determinants of FeLV infection and pathogenesis: lessons learned from analysis of a natural cohort. Viruses (2011) 0.87
Comparative Efficacy of Feline Leukemia Virus (FeLV) Inactivated Whole-Virus Vaccine and Canarypox Virus-Vectored Vaccine during Virulent FeLV Challenge and Immunosuppression. Clin Vaccine Immunol (2015) 0.86
Epizootiology and management of feline leukemia virus in the Florida puma. J Wildl Dis (2008) 0.85
Feline leukemia virus detection by immunohistochemistry and polymerase chain reaction in formalin-fixed, paraffin-embedded tumor tissue from cats with lymphosarcoma. Can J Vet Res (1993) 0.84
Exposure of cats to low doses of FeLV: seroconversion as the sole parameter of infection. Vet Res (2009) 0.84
Development and application of a quantitative real-time PCR assay to detect feline leukemia virus RNA. Vet Immunol Immunopathol (2008) 0.84
Prevalence and risk factors of feline leukaemia virus and feline immunodeficiency virus in peninsular Malaysia. BMC Vet Res (2012) 0.83
Evidence of horizontal transmission of feline leukemia virus by the cat flea ( Ctenocephalides felis). Parasitol Res (2003) 0.80
Dominance of highly divergent feline leukemia virus A progeny variants in a cat with recurrent viremia and fatal lymphoma. Retrovirology (2010) 0.80
Retroviral DNA-the silent winner: blood transfusion containing latent feline leukemia provirus causes infection and disease in naïve recipient cats. Retrovirology (2015) 0.79
Molecular detection, phylogenetic analysis, and identification of transcription motifs in feline leukemia virus from naturally infected cats in malaysia. Vet Med Int (2014) 0.78
Comparison of the geographical distribution of feline immunodeficiency virus and feline leukemia virus infections in the United States of America (2000-2011). BMC Vet Res (2013) 0.78
Identification of novel subgroup A variants with enhanced receptor binding and replicative capacity in primary isolates of anaemogenic strains of feline leukaemia virus. Retrovirology (2012) 0.78
Detection of antibodies to the feline leukemia Virus (FeLV) transmembrane protein p15E: an alternative approach for serological FeLV detection based on antibodies to p15E. J Clin Microbiol (2014) 0.76
Development and clinical evaluation of a rapid diagnostic kit for feline leukemia virus infection. J Vet Sci (2013) 0.75
Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med (2010) 12.08
Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J Virol (1999) 10.41
Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes. Science (1993) 8.49
Production of hepatitis B virus by a differentiated human hepatoma cell line after transfection with cloned circular HBV DNA. Cell (1986) 5.35
Photonic detection of bacterial pathogens in living hosts. Mol Microbiol (1995) 5.24
Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy. Nat Med (2000) 4.83
Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection. J Exp Med (2001) 4.42
Human immunodeficiency virus type 1 evolution in vivo tracked by DNA heteroduplex mobility assays. J Virol (1994) 4.35
HIV quasispecies and resampling. Science (1996) 3.98
The genome organization of STLV-3 is similar to that of the AIDS virus except for a truncated transmembrane protein. Cell (1987) 3.65
Sequence analysis and acute pathogenicity of molecularly cloned SIVSMM-PBj14. Nature (1990) 3.54
Viral transduction of c-myc gene in naturally occurring feline leukaemias. Nature (1984) 3.39
Multidrug-resistant human immunodeficiency virus type 1 strains resulting from combination antiretroviral therapy. J Virol (1996) 3.21
Molecular epidemiology of HIV transmission in a dental practice. Science (1992) 3.10
SIV adaptation to human cells. Nature (1989) 3.09
Large-scale monitoring of host cell gene expression during HIV-1 infection using cDNA microarrays. Virology (2000) 2.92
Quantitation of target molecules from polymerase chain reaction-based limiting dilution assays. AIDS Res Hum Retroviruses (1997) 2.91
Molecular cloning of a feline leukemia virus that induces fatal immunodeficiency disease in cats. Science (1988) 2.86
Lethal mutagenesis of HIV with mutagenic nucleoside analogs. Proc Natl Acad Sci U S A (1999) 2.85
Slower evolution of human immunodeficiency virus type 1 quasispecies during progression to AIDS. J Virol (1997) 2.72
Maintaining the integrity of human immunodeficiency virus sequence databases. J Virol (1996) 2.68
Strong sequence conservation among horizontally transmissible, minimally pathogenic feline leukemia viruses. J Virol (1988) 2.62
Cloning of HTLV-4 and its relation to simian and human immunodeficiency viruses. Nature (1987) 2.61
Disease-specific and tissue-specific production of unintegrated feline leukaemia virus variant DNA in feline AIDS. Nature (1986) 2.52
Antibodies to cell membrane antigens associated with human T-cell leukemia virus in patients with AIDS. Science (1983) 2.48
Nucleotide sequences of a feline leukemia virus subgroup A envelope gene and long terminal repeat and evidence for the recombinational origin of subgroup B viruses. J Virol (1986) 2.34
Nucleotide sequence of the envelope gene of Gardner-Arnstein feline leukemia virus B reveals unique sequence homologies with a murine mink cell focus-forming virus. J Virol (1983) 2.24
Sequence arrangement and biological activity of cloned feline leukemia virus proviruses from a virus-productive human cell line. J Virol (1981) 2.17
Divergent patterns of progression to AIDS after infection from the same source: human immunodeficiency virus type 1 evolution and antiviral responses. J Virol (1997) 2.16
Protection against lethal simian immunodeficiency virus SIVsmmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and by a gp120 subunit vaccine. J Virol (1996) 2.12
Identification of human immunodeficiency virus type 1 envelope genes recombinant between subtypes B and F in two epidemiologically linked individuals from Brazil. J Virol (1994) 2.05
Coalescent estimates of HIV-1 generation time in vivo. Proc Natl Acad Sci U S A (1999) 2.02
Functional comparison of transactivation by simian immunodeficiency virus from rhesus macaques and human immunodeficiency virus type 1. J Virol (1988) 2.00
Human immunodeficiency virus type 1 populations in blood and semen. J Virol (1998) 1.99
Genetic subtyping of human immunodeficiency virus using a heteroduplex mobility assay. PCR Methods Appl (1995) 1.96
Transduction of endogenous envelope genes by feline leukaemia virus in vitro. Nature (1988) 1.94
Genetic analysis of HIV-1 isolates from Brazil reveals presence of two distinct genetic subtypes. AIDS Res Hum Retroviruses (1994) 1.90
Molecular analysis and pathogenesis of the feline aplastic anemia retrovirus, feline leukemia virus C-Sarma. J Virol (1986) 1.84
Viral genetic determinants of T-cell killing and immunodeficiency disease induction by the feline leukemia virus FeLV-FAIDS. J Virol (1991) 1.83
Simian immunodeficiency virus DNA vaccine trial in macaques. J Virol (1996) 1.71
Rapid genetic characterization of HIV type 1 strains from four World Health Organization-sponsored vaccine evaluation sites using a heteroduplex mobility assay. WHO Network for HIV Isolation and Characterization. AIDS Res Hum Retroviruses (1994) 1.60
Identification of three feline immunodeficiency virus (FIV) env gene subtypes and comparison of the FIV and human immunodeficiency virus type 1 evolutionary patterns. J Virol (1994) 1.59
V3 region polymorphisms in HIV-1 from Brazil: prevalence of subtype B strains divergent from North American/European prototype and detection of subtype F. AIDS Res Hum Retroviruses (1994) 1.59
Evolution of human immunodeficiency virus type 1 envelope sequences in infected individuals with differing disease progression profiles. Virology (1998) 1.57
Genetic diversity of feline immunodeficiency virus: dual infection, recombination, and distinct evolutionary rates among envelope sequence clades. J Virol (1997) 1.55
Persistence of attenuated rev genes in a human immunodeficiency virus type 1-infected asymptomatic individual. J Virol (1995) 1.48
Posttranslational modifications distinguish the envelope glycoprotein of the immunodeficiency disease-inducing feline leukemia virus retrovirus. J Virol (1989) 1.48
Evolution of hepatitis C virus quasispecies in hypervariable region 1 and the putative interferon sensitivity-determining region during interferon therapy and natural infection. J Virol (1998) 1.46
Pathogenic and host range determinants of the feline aplastic anemia retrovirus. Proc Natl Acad Sci U S A (1988) 1.45
Nucleic acid sequence of an internal image-bearing monoclonal anti-idiotype and its comparison to the sequence of the external antigen. Proc Natl Acad Sci U S A (1986) 1.43
Genetic evaluation of suspected cases of transient HIV-1 infection of infants. Science (1998) 1.43
Distinct determinants of human immunodeficiency virus type 1 RNA and DNA loads in vaginal and cervical secretions. J Infect Dis (1998) 1.43
Sequence organization of feline leukemia virus DNA in infected cells. Nucleic Acids Res (1980) 1.42
Simian immunodeficiency virus displays complex patterns of RNA splicing. J Virol (1990) 1.39
Lethal mutagenesis of HIV by mutagenic ribonucleoside analogs. AIDS Res Hum Retroviruses (2000) 1.32
Molecular cloning and characterization of endogenous feline leukemia virus sequences from a cat genomic library. J Virol (1983) 1.30
Simian immunodeficiency virus-specific cytotoxic T-lymphocyte induction through DNA vaccination of rhesus monkeys. J Virol (1996) 1.29
Testing the hypothesis of a recombinant origin of human immunodeficiency virus type 1 subtype E. J Virol (2000) 1.26
Additional member of the protein-tyrosine kinase family: the src- and lck-related protooncogene c-tkl. Proc Natl Acad Sci U S A (1987) 1.24
Anti-HIV type 1 memory cytotoxic T lymphocyte responses associated with changes in CD4+ T cell numbers in progression of HIV type 1 infection. AIDS Res Hum Retroviruses (1998) 1.23
Primary subtype C HIV-1 infection in Harare, Zimbabwe. J Acquir Immune Defic Syndr Hum Retrovirol (1999) 1.22
Protecting HIV databases. Nature (1995) 1.22
Amplimers with 3'-terminal phosphorothioate linkages resist degradation by vent polymerase and reduce Taq polymerase mispriming. PCR Methods Appl (1992) 1.21
Experimental transmission and pathogenesis of immunodeficiency syndrome in cats. Blood (1987) 1.20
Feline leukemia virus subgroup C phenotype evolves through distinct alterations near the N terminus of the envelope surface glycoprotein. Proc Natl Acad Sci U S A (1992) 1.18
Identification of an env G subtype and heterogeneity of HIV-1 strains in the Russian Federation and Belarus. AIDS (1994) 1.18
Lymphocyte subset alterations and viral determinants of immunodeficiency disease induction by the feline leukemia virus FeLV-FAIDS. J Virol (1990) 1.18
Rates of amino acid change in the envelope protein correlate with pathogenicity of primate lentiviruses. J Mol Evol (1993) 1.17
The U3 portion of feline leukemia virus DNA identifies horizontally acquired proviruses in leukemic cats. Proc Natl Acad Sci U S A (1981) 1.16
Evolution of a simian immunodeficiency virus pathogen. J Virol (1998) 1.15
Early pathogenesis of disease caused by SIVsmmPBj14 molecular clone 1.9 in macaques. AIDS Res Hum Retroviruses (1993) 1.14
Position and degree of mismatches and the mobility of DNA heteroduplexes. Nucleic Acids Res (2000) 1.14
Human immunodeficiency virus type 1 molecular evolution and the measure of selection. AIDS Res Hum Retroviruses (1996) 1.11
Cytopathicity of human immunodeficiency virus type 1 primary isolates depends on coreceptor usage and not patient disease status. J Virol (2001) 1.10
Cloned genomic segments of Zea mays homologous to zein mRNAs. Gene (1981) 1.09
Covariability of V3 loop amino acids. AIDS Res Hum Retroviruses (1996) 1.09
Efficient amplification of HIV half-genomes from tissue DNA. Nucleic Acids Res (1992) 1.08
Distribution of HIV-1 subtypes seen in an AIDS clinic in Sao Paulo City, Brazil. AIDS (1996) 1.07
Cross-reactivity to human T-lymphotropic virus type III/lymphadenopathy-associated virus and molecular cloning of simian T-cell lymphotropic virus type III from African green monkeys. Proc Natl Acad Sci U S A (1986) 1.06
Cervical human immunodeficiency virus type 1 shedding is associated with genital beta-chemokine secretion. J Infect Dis (1998) 1.06
Characterization and significance of delayed processing of the feline leukemia virus FeLV-FAIDS envelope glycoprotein. J Virol (1990) 1.05
Genital tract human immunodeficiency virus type 1 (HIV-1) shedding and inflammation and HIV-1 env diversity in perinatal HIV-1 transmission. J Infect Dis (2000) 1.04
Mother-to-infant transmission of human immunodeficiency virus type 1 involving five envelope sequence subtypes. J Virol (1997) 1.04
Site-directed mutagenesis using uracil-containing double-stranded DNA templates and DpnI digestion. Biotechniques (1999) 1.02
Conserved V3 loop sequences and transmission of human immunodeficiency virus type 1. AIDS Res Hum Retroviruses (1994) 1.01
Structure and pathogenicity of individual variants within an immunodeficiency disease-inducing isolate of FeLV. Virology (1992) 1.00
HIV-1 dynamics in children. J Acquir Immune Defic Syndr Hum Retrovirol (1999) 0.99
The role of feline leukaemia virus in naturally occurring leukaemias. Cancer Surv (1987) 0.99
Selection against CpG dinucleotides in lentiviral genes: a possible role of methylation in regulation of viral expression. Nucleic Acids Res (1990) 0.98
Distinct superinfection interference properties yet similar receptor utilization by cytopathic and noncytopathic feline leukemia viruses. J Virol (1993) 0.98
Analysis of a feline immunodeficiency virus provirus reveals patterns of gene sequence conservation distinct from human immunodeficiency virus type 1. AIDS Res Hum Retroviruses (1995) 0.98
Interference with superinfection and with cell killing and determination of host range and growth kinetics mediated by feline leukemia virus surface glycoproteins. J Virol (1993) 0.98
Correlation between phosphorylated H1 histones and satellite DNAs in Drosophila virilis. Proc Natl Acad Sci U S A (1978) 0.97
Virologic studies in a case of transfusion-associated AIDS. N Engl J Med (1984) 0.95
Should patients with drug-resistant HIV-1 continue to receive antiretroviral therapy? N Engl J Med (2001) 0.94
Substitution model of sequence evolution for the human immunodeficiency virus type 1 subtype B gp120 gene over the C2-V5 region. J Mol Evol (2001) 0.93
Induction of aplastic anemia by intra-bone marrow inoculation of a molecularly cloned feline retrovirus. Leuk Res (1989) 0.93